skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Underestimation of glucose turnover measured with (6-/sup 3/H)- and (6,6-/sup 2/H)- but not (6-/sup 14/C)glucose during hyperinsulinemia in humans

Journal Article · · Diabetes; (United States)
OSTI ID:6442571

Recent studies indicate that hydrogen-labeled glucose tracers underestimate glucose turnover in humans under conditions of high flux. The cause of this underestimation is unknown. To determine whether the error is time-, pool-, model-, or insulin-dependent, glucose turnover was measured simultaneously with (6-3H)-, (6,6-2H2)-, and (6-14C)glucose during a 7-h infusion of either insulin (1 mU.kg-1.min-1) or saline. During the insulin infusion, steady-state glucose turnover measured with both (6-3H)glucose (8.0 +/- 0.5 mg.kg-1.min-1) and (6,6-2H2)glucose (7.6 +/- 0.5 mg.kg-1.min-1) was lower (P less than .01) than either the glucose infusion rate required to maintain euglycemia (9.8 +/- 0.7 mg.kg-1.min-1) or glucose turnover determined with (6-14C)glucose and corrected for Cori cycle activity (9.8 +/- 0.7 mg.kg-1.min-1). Consequently negative glucose production rates (P less than .01) were obtained with either (6-3H)- or (6,6-2H2)- but not (6-14C)glucose. The difference between turnover estimated with (6-3H)glucose and actual glucose disposal (or 14C glucose flux) did not decrease with time and was not dependent on duration of isotope infusion. During saline infusion, estimates of glucose turnover were similar regardless of the glucose tracer used. High-performance liquid chromatography of the radioactive glucose tracer and plasma revealed the presence of a tritiated nonglucose contaminant. Although the contaminant represented only 1.5% of the radioactivity in the (6-3H)glucose infusate, its clearance was 10-fold less (P less than .001) than that of (6-3H)glucose. This resulted in accumulation in plasma, with the contaminant accounting for 16.6 +/- 2.09 and 10.8 +/- 0.9% of what customarily is assumed to be plasma glucose radioactivity during the insulin or saline infusion, respectively (P less than .01).

Research Organization:
Mayo Clinic, Rochester, MN (USA)
OSTI ID:
6442571
Journal Information:
Diabetes; (United States), Vol. 38:1
Country of Publication:
United States
Language:
English